Literature DB >> 26396792

Crystal structure of (R)-6-fluoro-2-[(S)-oxiran-2-yl]chroman.

Yoann Rousselin1, Hugo Laureano2, Alexandre Clavel2.   

Abstract

The title compound, C11H11FO2, is a building block in the synthesis of the active pharmaceutical ingredient dl-nebivolol. The synthesis starting from the enanti-omerically pure (R)-6-fluoro-4-oxo-3,4-di-hydro-2H-chromene-2-carb-oxy-lic acid resulted in a mixture of two stereoisomers, namely (R)-6-fluoro-2-[(S)-oxiran-2-yl]chroman and (R)-6-fluoro-2-[(R)-oxiran-2-yl]chroman. The mixture was separated by column chromatography but only one stereoisomer crystallized. The X-ray structure analysis revealed that the solid consisted of the R,S isomer. A similar procedure was repeated for (S)-6-fluoro-4-oxo-3,4-di-hydro-2H-chromene-2-carb-oxy-lic acid and, in this case, the S,R isomer was produced as a crystalline solid. Thus, all four stereoisomers of the title epoxide were obtained and their absolute configuration was assigned. The crystal studied was refined as an inversion twin.

Entities:  

Keywords:  absolute configuration; crystal structure; nebivolol

Year:  2015        PMID: 26396792      PMCID: PMC4571392          DOI: 10.1107/S205698901501261X

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Related literature

For the synthesis of the enanti­opure title product, see: Jas et al. (2011 ▸). For pharmacological properties of nebivolol, see: Van Lommen et al. (1990 ▸). For a study of related isomers, see: Horiguchi et al. (1997 ▸). For the determination of absolute structure, see: Flack (2003 ▸).

Experimental

Crystal data

C11H11FO2 M = 194.20 Monoclinic, a = 9.3742 (3) Å b = 4.76845 (12) Å c = 11.0212 (3) Å β = 114.202 (4)° V = 449.35 (3) Å3 Z = 2 Cu Kα radiation μ = 0.94 mm−1 T = 100 K 0.05 × 0.05 × 0.02 mm

Data collection

Agilent SuperNova Dual Source diffractometer with an Atlas detector Absorption correction: multi-scan (CrysAlis PRO; Agilent, 2012 ▸) T min = 0.64, T max = 1 14207 measured reflections 1847 independent reflections 1820 reflections with I > 2σ(I) R int = 0.050

Refinement

R[F 2 > 2σ(F 2)] = 0.032 wR(F 2) = 0.092 S = 1.10 1847 reflections 128 parameters 1 restraint H-atom parameters constrained Δρmax = 0.20 e Å−3 Δρmin = −0.16 e Å−3 Absolute structure: crystal refined as an inversion twin (Flack, 2003 ▸) Absolute structure parameter: 0.0 (2)

Data collection: CrysAlis PRO (Agilent, 2012 ▸); cell refinement: CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▸); program(s) used to refine structure: SHELXL2014 (Sheldrick, 2015 ▸); molecular graphics: OLEX2 (Dolomanov et al., 2009 ▸); software used to prepare material for publication: OLEX2. Crystal structure: contains datablock(s) I, New_Global_Publ_Block. DOI: 10.1107/S205698901501261X/gk2636sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S205698901501261X/gk2636Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S205698901501261X/gk2636Isup3.mol Click here for additional data file. Supporting information file. DOI: 10.1107/S205698901501261X/gk2636Isup4.cml Click here for additional data file. . DOI: 10.1107/S205698901501261X/gk2636fig1.tif View of the mol­ecular structure of the title compound with 50% probability displacement ellipsoids for the non-hydrogen atoms. Click here for additional data file. . DOI: 10.1107/S205698901501261X/gk2636fig2.tif Reaction scheme for the synthesis of nebivolol CCDC reference: 1409735 Additional supporting information: crystallographic information; 3D view; checkCIF report
C11H11FO2F(000) = 204
Mr = 194.20Dx = 1.435 Mg m3
Monoclinic, P21Cu Kα radiation, λ = 1.54184 Å
a = 9.3742 (3) ÅCell parameters from 7897 reflections
b = 4.76845 (12) Åθ = 4.4–76.3°
c = 11.0212 (3) ŵ = 0.94 mm1
β = 114.202 (4)°T = 100 K
V = 449.35 (3) Å3Needle, colourless
Z = 20.05 × 0.05 × 0.02 mm
Agilent SuperNova Dual Source diffractometer with an Atlas detector1847 independent reflections
Radiation source: SuperNova (Cu) X-ray Source1820 reflections with I > 2σ(I)
Mirror monochromatorRint = 0.050
Detector resolution: 5.2474 pixels mm-1θmax = 76.5°, θmin = 4.4°
CCD rotation images, thick slices scansh = −11→11
Absorption correction: multi-scan (CrysAlis PRO; Agilent, 2012)k = −5→5
Tmin = 0.64, Tmax = 1l = −13→13
14207 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.032H-atom parameters constrained
wR(F2) = 0.092w = 1/[σ2(Fo2) + (0.0529P)2 + 0.0952P] where P = (Fo2 + 2Fc2)/3
S = 1.10(Δ/σ)max < 0.001
1847 reflectionsΔρmax = 0.20 e Å3
128 parametersΔρmin = −0.16 e Å3
1 restraintAbsolute structure: crystal refined as an inversion twin (Flack, 2003)
0 constraintsAbsolute structure parameter: 0.0 (2)
Experimental. Analyzes were recorded in the "Pole Chimie Moleculaire", the technological platform for chemical analysis and molecular synthesis (http://www.wpcm.fr) which relies on the Institute of the Molecular Chemistry of University of Burgundy and Welience"TM", a Burgundy University private subsidiary.1H and 13C NMR measurements were performed in deuterated methanol on Bruker Avance III, recorded at 500 MHz and 125 MHz, respectively. Chemical shifts (δ) and coupling constants are reported respectively in p.p.m. and hertz (Hz). The optical rotation was measured using a UV Visible Perkin Elmer Lambda 12, polarimeter at 589 nm. High-resolution mass spectrometry (HRMS) was performed in ESI a positive mode. The infrared spectrum (IR) was generated by ATR using a Spectrometer Infrared Avatar 370. A scan range of 4000 - 400 cm-1 was used.(2S,2R)-(6-fluoro-2-chromanyl)oxirane:δ(1H, DMSO-d6, 300 MHz, ppm): 1.72 (1H, m); 2.00 (1H, m); 2.74 (2H, m); 2.82 (2H, m); 3.17 (1H, ddd); 3.94 (1H, ddd); 6.77 (1H, dd); 6.92 (2H, m).δ(13C DMSO-d6, 75.47MHz, ppm): 23.4, 23.7, 44.5, 52.3, 75.3, 113.7 (d, 23.2 Hz), 115.2 (d, 22.3 Hz), 117.2 (d, 8.2 Hz), 123.5(d, 7.5 Hz), 150.1 (d, 1.5 Hz), 156.0(d, 234.8 Hz).[α]29D +67.5o (c =1.0 in CHCl3)HRMS (ESI) for C18H21FNO2[M+H]+ m/z = 195.08158, found m/z = 195.08120.IR (cm-1) 3050, 3001, 2951, 1492, 1220Data CCDC-1407326 contains the enantiomer structure of (S)-6-Fluoro-2-[(R)-oxiran-2-yl]chroman. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refined as a 2-component inversion twin.
xyzUiso*/Ueq
C10.7376 (2)0.5622 (5)0.50701 (19)0.0255 (4)
C60.8296 (2)0.4711 (5)0.4448 (2)0.0254 (4)
H60.90950.33660.48700.030*
C50.8061 (2)0.5754 (4)0.32005 (19)0.0226 (4)
C40.6872 (2)0.7732 (4)0.26151 (18)0.0214 (4)
C30.5962 (2)0.8655 (5)0.3267 (2)0.0255 (4)
H30.51651.00090.28570.031*
C20.6216 (2)0.7604 (5)0.4512 (2)0.0261 (4)
H20.56080.82310.49680.031*
C70.9061 (2)0.4801 (4)0.24929 (19)0.0253 (4)
H7A0.87590.28680.21570.030*
H7B1.01720.47700.31320.030*
C80.8876 (2)0.6721 (5)0.13380 (19)0.0240 (4)
H8A0.93060.58030.07550.029*
H8B0.94580.84880.16780.029*
C90.7148 (2)0.7350 (5)0.05528 (19)0.0235 (4)
H90.65680.55390.02670.028*
C100.6765 (2)0.9185 (5)−0.0645 (2)0.0271 (4)
H100.56510.9814−0.10820.033*
C110.7573 (2)0.8967 (5)−0.1530 (2)0.0286 (5)
H11A0.83770.7487−0.13400.034*
H11B0.69680.9384−0.24850.034*
O10.65326 (15)0.8871 (3)0.13795 (13)0.0246 (3)
O20.79031 (19)1.1254 (4)−0.06003 (15)0.0329 (4)
F10.76157 (14)0.4549 (3)0.62882 (12)0.0333 (3)
U11U22U33U12U13U23
C10.0249 (9)0.0259 (10)0.0236 (9)−0.0037 (8)0.0079 (7)−0.0017 (8)
C60.0206 (8)0.0216 (10)0.0299 (10)0.0010 (7)0.0064 (7)0.0003 (8)
C50.0191 (8)0.0202 (10)0.0261 (9)−0.0036 (8)0.0070 (7)−0.0049 (8)
C40.0185 (8)0.0201 (10)0.0238 (9)−0.0035 (8)0.0070 (7)−0.0029 (8)
C30.0214 (9)0.0265 (11)0.0276 (9)0.0035 (7)0.0090 (7)−0.0011 (8)
C20.0245 (9)0.0274 (11)0.0282 (10)−0.0013 (8)0.0128 (8)−0.0051 (8)
C70.0224 (8)0.0220 (10)0.0303 (9)0.0040 (8)0.0097 (8)−0.0013 (8)
C80.0180 (8)0.0252 (10)0.0288 (9)0.0010 (7)0.0096 (7)−0.0042 (8)
C90.0201 (8)0.0252 (11)0.0266 (9)0.0009 (7)0.0109 (7)−0.0042 (8)
C100.0225 (9)0.0309 (11)0.0273 (9)0.0016 (8)0.0096 (7)−0.0015 (9)
C110.0272 (9)0.0315 (11)0.0286 (9)−0.0033 (9)0.0130 (8)−0.0049 (9)
O10.0224 (6)0.0275 (8)0.0247 (6)0.0066 (6)0.0106 (5)0.0019 (6)
O20.0442 (9)0.0260 (9)0.0323 (7)−0.0047 (7)0.0195 (6)−0.0041 (6)
F10.0343 (6)0.0384 (8)0.0268 (6)0.0030 (6)0.0121 (5)0.0062 (6)
C1—C61.374 (3)C7—C81.519 (3)
C1—C21.381 (3)C8—H8A0.9900
C1—F11.366 (2)C8—H8B0.9900
C6—H60.9500C8—C91.521 (2)
C6—C51.392 (3)C9—H91.0000
C5—C41.399 (3)C9—C101.500 (3)
C5—C71.514 (2)C9—O11.456 (2)
C4—C31.393 (3)C10—H101.0000
C4—O11.377 (2)C10—C111.463 (3)
C3—H30.9500C10—O21.439 (3)
C3—C21.387 (3)C11—H11A0.9900
C2—H20.9500C11—H11B0.9900
C7—H7A0.9900C11—O21.440 (3)
C7—H7B0.9900
C6—C1—C2122.35 (18)C7—C8—H8B109.9
F1—C1—C6119.21 (18)C7—C8—C9108.92 (16)
F1—C1—C2118.43 (17)H8A—C8—H8B108.3
C1—C6—H6119.9C9—C8—H8A109.9
C1—C6—C5120.12 (19)C9—C8—H8B109.9
C5—C6—H6119.9C8—C9—H9108.9
C6—C5—C4118.06 (17)C10—C9—C8115.48 (16)
C6—C5—C7121.35 (18)C10—C9—H9108.9
C4—C5—C7120.59 (17)O1—C9—C8110.18 (15)
C3—C4—C5121.04 (18)O1—C9—H9108.9
O1—C4—C5122.66 (16)O1—C9—C10104.31 (16)
O1—C4—C3116.30 (17)C9—C10—H10115.1
C4—C3—H3119.9C11—C10—C9122.88 (19)
C2—C3—C4120.19 (19)C11—C10—H10115.1
C2—C3—H3119.9O2—C10—C9117.62 (16)
C1—C2—C3118.22 (17)O2—C10—H10115.1
C1—C2—H2120.9O2—C10—C1159.51 (13)
C3—C2—H2120.9C10—C11—H11A117.8
C5—C7—H7A109.3C10—C11—H11B117.8
C5—C7—H7B109.3H11A—C11—H11B115.0
C5—C7—C8111.62 (16)O2—C11—C1059.42 (13)
H7A—C7—H7B108.0O2—C11—H11A117.8
C8—C7—H7A109.3O2—C11—H11B117.8
C8—C7—H7B109.3C4—O1—C9115.60 (15)
C7—C8—H8A109.9C10—O2—C1161.08 (13)
C1—C6—C5—C40.0 (3)C7—C5—C4—O11.0 (3)
C1—C6—C5—C7179.71 (17)C7—C8—C9—C10−178.77 (17)
C6—C1—C2—C31.3 (3)C7—C8—C9—O163.4 (2)
C6—C5—C4—C30.7 (3)C8—C9—C10—C1138.9 (3)
C6—C5—C4—O1−179.29 (18)C8—C9—C10—O2−31.0 (3)
C6—C5—C7—C8−165.51 (18)C8—C9—O1—C4−49.5 (2)
C5—C4—C3—C2−0.4 (3)C9—C10—C11—O2−105.1 (2)
C5—C4—O1—C917.2 (2)C9—C10—O2—C11113.8 (2)
C5—C7—C8—C9−44.7 (2)C10—C9—O1—C4−174.00 (14)
C4—C5—C7—C814.2 (2)O1—C4—C3—C2179.56 (17)
C4—C3—C2—C1−0.5 (3)O1—C9—C10—C11159.93 (19)
C3—C4—O1—C9−162.78 (17)O1—C9—C10—O290.0 (2)
C2—C1—C6—C5−1.0 (3)F1—C1—C6—C5179.30 (18)
C7—C5—C4—C3−178.99 (18)F1—C1—C2—C3−179.04 (19)
  3 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Synthesis and pharmacological properties of nebivolol, a new antihypertensive compound.

Authors:  G Van Lommen; M De Bruyn; M Schroven
Journal:  J Pharm Belg       Date:  1990 Nov-Dec

3.  Crystal structure refinement with SHELXL.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr C Struct Chem       Date:  2015-01-01       Impact factor: 1.172

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.